company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19429806.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19429806.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,675734.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1689324.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3174246.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,96115521.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,82225019.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,82287447.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-615420.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-143571573.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-89186993.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-89186993.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-704623.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,614973.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-89650.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-89650.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6989196.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q3,2009-07-01,2009-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1084473.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22473119.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22473119.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,687817.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1545898.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3591657.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3779654.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12868093.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12915121.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,755764.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1279000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-31480932.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,71750000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,39745832.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,39745832.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5489700.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,264927.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5224773.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5224773.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21605938.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2009.0,Q4,2009-10-01,2009-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,881069.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21115000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21115000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,838000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1249000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3274000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8273000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24027000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24027000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-456000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6612000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-31113000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96750000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,58569000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,58569000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-232000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4108000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3876000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3876000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,38418000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 07:29:47+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,541000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6763000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6763000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,943000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,883000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4735000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-25819000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26021000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26021000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-918000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-183000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-93552000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,109750000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15097000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15097000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-604000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1464000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,860000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,860000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10064000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,2010-04-01,2010-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1196000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12438000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12438000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1037000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,839000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4841000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10090000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,29245000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,29245000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-833000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-99000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-93197000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69750000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-24379000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-24379000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-555000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2426000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1871000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1871000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6737000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,2010-07-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1113000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3671000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3671000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1133000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1598000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4890000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9704000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1588000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1588000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-239000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-104000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-93093000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49500000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-43936000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-43936000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5459000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,372000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5416000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5416000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-47764000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,931000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-672000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-672000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1139000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1899000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3741000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18229000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12122000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12122000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-743000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-164000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42812000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,99500000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,55781000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,55781000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-235000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,392000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,157000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,157000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,43816000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,429000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 15:39:34+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,102000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-285000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-285000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1036000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1624000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5154000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4801000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2728000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2728000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-338000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-448000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-92699000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58500000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-34985000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-34985000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-706000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3141000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2435000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2435000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29822000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1048000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,2011-04-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18868000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18868000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1033000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,14636000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7052000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1171000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,42760000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,42760000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-151000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-251000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68478000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46880000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46880000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-413000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,283000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-130000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-130000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4250000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,917000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,2011-07-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,34000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12694000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12694000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1417000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-11305000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18093000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12071000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,32970000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,32970000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-960000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2732000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-62747000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,47500000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18939000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18939000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-608000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,146000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-462000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-462000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13569000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1010000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1025000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7846000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7846000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,912000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1537000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3737000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11020000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3012000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3012000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3104000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-656000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65396000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,61750000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7406000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7406000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-209000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1949000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1740000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1740000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2654000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,304000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 11:03:17+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,165000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4545000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4545000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1040000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1244000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5735000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-213000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12351000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12351000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3314000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-282000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-72493000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3089000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3089000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-267000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,422000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,155000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,155000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9417000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,310000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,628000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9594000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9594000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1098000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,977000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5693000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2653000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,20015000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,20015000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2749000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-927000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-94744000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53500000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44920000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44920000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-336000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,550000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,214000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,214000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24691000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,267000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,2012-07-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,304000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,132973000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,132973000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1613000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,691000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6561000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-125097000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16741000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16741000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1217000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89822000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76500000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15868000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15868000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-441000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1418000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,977000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,977000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1850000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,241000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1609000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1139000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1139000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1400000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,602000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4896000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13414000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7655000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7655000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1060000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-641000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27471000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1172000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1172000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-265000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1903000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1638000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1638000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7189000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,466000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 16:56:49+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,731000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3911000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3911000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1512000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,595000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6333000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4043000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8308000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8308000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1668000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1023000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32070000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2761000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2761000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-269000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2737000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2468000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2468000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8015000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,593000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,2013-04-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,606000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7478000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7478000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1711000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,614000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6554000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3085000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,19442000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,19442000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-935000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8353000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68497000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54500000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23285000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23285000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-136000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7543000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7407000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7407000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3564000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,636000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,405000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6191000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6191000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2376000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,765000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7228000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2630000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,19190000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,19190000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-380000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-603000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-93391000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76500000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17874000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17874000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-239000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,603000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,91000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,455000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,455000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1771000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,327000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,888000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,703000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,703000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1759000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,743000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5805000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4705000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4305000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4305000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-942000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1198000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-93797000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,84500000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11437000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11437000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-212000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3662000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3450000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3450000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3682000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,415000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,2014-01-01,2014-03-31,2015-05-08 17:18:09+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,460000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4687000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4687000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1865000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,913000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7645000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3597000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18707000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18707000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-448000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-88000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-170051000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-126587000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-126587000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7589000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,345000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,713000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,338124000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,338124000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,230244000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,291000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,754000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11952000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11952000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1751000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3688000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7114000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13915000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,38420000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,38420000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-940000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-291000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-316533000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-262764000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-262764000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-167000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3253000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3086000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3086000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-221258000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,447000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,615000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,330000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,330000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3098000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2545000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15402000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8158000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13217000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13217000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2754000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-477273000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,586990000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,106963000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,106963000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-110000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8387000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,371000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8648000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8648000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,128829000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3369000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2563000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3085000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3085000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3707000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2660000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7126000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19658000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9250000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9250000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2571000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-152000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-169563000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,56250000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-116036000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-116036000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-110000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4741000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4631000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4631000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-120655000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,463000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 17:08:50+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,743000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,997000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,997000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3784000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3011000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8708000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13250000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3250000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3250000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1486000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-420000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-106424000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,118250000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9920000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9920000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-15000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1527000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1512000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1512000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14682000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3523000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,580000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3941000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3941000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3662000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3099000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8914000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2540000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22156000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22156000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-968000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-209000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-83981000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10158000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10158000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-90000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1732000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1642000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1642000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13640000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,293000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,829000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9205000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9205000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3859000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3158000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8525000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2422000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22325000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22325000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-896000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-364000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-74702000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,107000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31038000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31038000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-286000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10096000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,194000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10004000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10004000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,63367000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2939000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2545000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-520000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-520000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3949000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2699000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2130000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2699000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,6697000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,6697000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1037000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-406000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40214000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,239966000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,198309000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,198309000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,73229000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,73204000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,73204000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,278210000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,21000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:15:38+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,157000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18958000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18958000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5967000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2332000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9078000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7969000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9550000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9550000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1467000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-275082000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-269556000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-269556000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1520000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-14489000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-25000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,822000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-15162000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-15162000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,254000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-294014000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3019000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2421000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13031000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13031000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5859000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2594000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9960000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,343000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5725000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5725000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2129000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,6899000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,7000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-7000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2223000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2223000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-80000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-13457000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,622000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-12915000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-12915000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-47000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9460000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,986000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18904000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18904000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5647000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2580000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8119000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22861000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25419000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25419000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5773000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-76000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5849000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5849000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2225000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5474000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2722000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5971000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5971000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,361000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24936000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,29000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 07:22:58+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1915000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8195000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8195000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6076000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3785000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10744000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2151000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10259000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10259000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2974000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-131000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3105000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3105000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-184000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-60000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-244000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-244000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,545000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7455000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3018000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5767000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25196000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25196000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5761000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2553000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,46094000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,22551000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,51763000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,51763000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1623000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-87000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1710000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1710000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1527000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1527000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1527000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,154000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,51734000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3681000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-171064000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-171064000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5750000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3235000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,258628000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-36016000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,60533000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,60533000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3318000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-394000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3663000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,2722000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3478000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,48065000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54265000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54265000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-1060000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,113689000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3019000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3566000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8199000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8199000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3310000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3911000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3085000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26594000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,28701000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,28701000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4807000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-106767000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-111579000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-111579000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-656000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1202000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3367000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1509000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1509000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-80991000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,26000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:09:28+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,465000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13911000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13911000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2470000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3215000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2634000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,83764000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,78172000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,78172000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11755000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-213000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43281000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,52539000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2710000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2710000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2251000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2251000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2251000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-238000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,77559000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3111000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9595000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9595000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2361000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3295000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-5296000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22293000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12338000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12338000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10780000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-212000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57455000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,7884000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45734000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14829000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14829000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-157000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,220000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,62000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,62000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,238000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26867000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3019000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4044000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47605000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47605000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4850000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4196000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1200000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-40137000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-77496000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-77496000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24655000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48685000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55219000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18121000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18121000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-614000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-52000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-642000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-642000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-96259000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,18000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:17:19+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,19000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27486000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27486000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10028000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3300000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2016000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2749000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14891000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14891000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-32615000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59214000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,56723000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35106000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35106000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-39000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-39000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-39000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49996000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3019000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1006000.0
